Axsome Therapeutics Inc
NASDAQ:AXSM

Watchlist Manager
Axsome Therapeutics Inc Logo
Axsome Therapeutics Inc
NASDAQ:AXSM
Watchlist
Price: 98.0819 USD 0.26%
Market Cap: 4.7B USD
Have any thoughts about
Axsome Therapeutics Inc?
Write Note

Axsome Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Axsome Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Axsome Therapeutics Inc
NASDAQ:AXSM
Cash from Operating Activities
-$192.7m
CAGR 3-Years
-29%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Operating Activities
$25.1B
CAGR 3-Years
-1%
CAGR 5-Years
2%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Operating Activities
$15B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
14%
Pfizer Inc
NYSE:PFE
Cash from Operating Activities
$8B
CAGR 3-Years
-37%
CAGR 5-Years
-10%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Cash from Operating Activities
$18.3B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
4%
Eli Lilly and Co
NYSE:LLY
Cash from Operating Activities
$6B
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
2%

See Also

What is Axsome Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-192.7m USD

Based on the financial report for Jun 30, 2024, Axsome Therapeutics Inc's Cash from Operating Activities amounts to -192.7m USD.

What is Axsome Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-42%

Over the last year, the Cash from Operating Activities growth was -73%. The average annual Cash from Operating Activities growth rates for Axsome Therapeutics Inc have been -29% over the past three years , -42% over the past five years .

Back to Top